The festive season is officially upon us and that means it's time to update our Christmas playlists, queue up Christmas movies on Netflix, and shop for Christmas presents (even if we plan on keeping ...

One of my favorite jokes requires a little setup. It’s from the first “Naked Gun” movie, from 1988, starring Leslie Nielsen as the bumbling Los Angeles police detective Frank Drebin and Priscilla ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Eric Idle has revealed George Harrison had a surprisingly morbid but uplifting way of comforting his friends – by reminding them, with a smile, that they were going to die. Their friendship began at a ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Audiences can still look forward to hearing the tour’s namesake song, “Always Look on the Bright Side of Life,” from Monty Python’s Life of Brian. And Idle noted that he’s especially gratified to hear ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...